No licensing board may revoke, fail to renew, suspend, or take any action against a health care provider’s license pursuant to the provisions of chapter 36-4, based solely on the health care provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product, or device. No entity responsible for Medicare certification may take action against a health care provider’s Medicare certification based solely on the health care provider’s recommendation regarding an investigational drug, biological product, or device.

Ask a legal question, get an answer ASAP!
Click here to chat with a lawyer about your rights.

Source: SL 2015, ch 188, § 7.